Laboratory-based investigation of suspected mumps cases submitted to the German National Reference Centre for Measles, Mumps, and Rubella, 2008 to 2013

International Journal of Medical Microbiology

Volumn 305, Issue 7, 2015, Pages 619-626

  Mankertz, Annette ^a   Beutel, Ulrike ^b   Schmidt, Franz Josef ^c   Borgmann, Stefan ^d   Wenzel, Jürgen J ^e   Ziegler, Peter ^f   Weißbrich, Benedikt ^g   Santibanez, Sabine ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b Department of Clinical Infectiology and Infection Control ^*  (Germany)

^c Regensburg University Medical Center ^*  (Germany)

^d KLINIKUM INGOLSTADT   (Germany)

^e UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^f Public Health Department Landshut   (Germany)

^g UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

German Reference Centre; Laboratory confirmation test; Molecular surveillance; Mumps virus; Vaccination; Vaccination failure

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; ARTICLE; BODY FLUID; EPIDEMIC; FEMALE; GENDER; GENOTYPE; GROUPS BY AGE; HUMAN; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; PHYLOGENY; POLYMERASE CHAIN REACTION; SEROLOGY; THROAT CULTURE; VACCINATION; VACCINE FAILURE; VIRUS CULTURE; AGE DISTRIBUTION; CLASSIFICATION; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; GERMANY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; SEX RATIO; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; FALSE NEGATIVE REACTIONS; FEMALE; GENOTYPE; GERMANY; HUMANS; MALE; MUMPS; MUMPS VIRUS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 84944278250     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2015.08.011     Document Type: Article

References (39)

1. Aasheim E.T., Inns T., Trindall A., Emmett L., Brown K.E., Williams C.J., Reacher M. Outbreak of mumps in a school setting, United Kingdom, 2013. Hum. Vaccines Immunother. 2014, 10:2446-2449.
2. Barskey A.E., Schulte C., Rosen J.B., Handschur E.F., Rausch-Phung E., Doll M.K., Cummings K.P., Alleyne E.O., High P., Lawler J., Apostolou A., Blog D., Zimmerman C.M., Montana B., Harpaz R., Hickman C.J., Rota P.A., Rota J.S., Bellini W.J., Gallagher K.M. Mumps outbreak in Orthodox Jewish communities in the United States. N. Engl. J. Med. 2012, 367:1704-1713.
3. Borgmann S., Schwab F., Santibanez S., Mankertz A. Mumps virus infection in vaccinated patients can be detected by an increase in specific IgG antibodies to high titres: a retrospective study. Epidemiol. Infect. 2014, 142:2388-2396.
4. Brockhoff H.J., Mollema L., Sonder G.J., Postema C.A., van Binnendijk R.S., Kohl R.H., de Melker H.E., Hahne S.J. Mumps outbreak in a highly vaccinated student population, The Netherlands, 2004. Vaccine 2010, 28:2932-2936.
5. Cortese M.M., Barskey A.E., Tegtmeier G.E., Zhang C., Ngo L., Kyaw M.H., Baughman A.L., Menitove J.E., Hickman C.J., Bellini W.J., Dayan G.H., Hansen G.R., Rubin S. Mumps antibody levels among students before a mumps outbreak: in search of a correlate of immunity. J. Infect. Dis. 2011, 204:1413-1422.
6. Deeks S.L., Lim G.H., Simpson M.A., Gagne L., Gubbay J., Kristjanson E., Fung C., Crowcroft N.S. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ: Can. Med. Assoc. J. 2011, 183:1014-1020. (Journal de l'Association Medicale Canadienne).
7. Fanoy E.B., Cremer J., Ferreira J.A., Dittrich S., van Lier A., Hahne S.J., Boot H.J., van Binnendijk R.S. Transmission of mumps virus from mumps-vaccinated individuals to close contacts. Vaccine 2011, 29:9551-9556.
8. Fontana J.M., Bankamp B., Bellini W.J., Rota P.A. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 2008, 374:71-81.
9. Gonzalez P.P., Barrios J.A., Morales Serna J.C. Study of a population-wide epidemic outbreak of mumps virus G1 in Jerez de la Frontera (Spain). Aten. Primaria 2012, 44:320-327. (Sociedad Espanola de Medicina de Familia y Comunitaria).
10. Gouma S., Sane J., Gijselaar D., Cremer J., Hahne S., Koopmans M., van Binnendijk R. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009-2012). J. Gen. Virol. 2014, 95:1074-1082.
11. Harling R., White J.M., Ramsay M.E., Macsween K.F., van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine 2005, 23:4070-4074.
12. Hatchette T., Davidson R., Clay S., Pettipas J., Leblanc J., Sarwal S., Smieja M., Forward K. Laboratory diagnosis of mumps in a partially immunized population: the Nova Scotia experience. J. Can. Maladies Infect. Microbiol. Med./AMMI Canada 2009, 20:e157-e162.
13. Haywood B., Patel M., Hurday S., Copping R., Webster D., Irish D., Haque T. Comparison of automated chemiluminescence immunoassays with capture enzyme immunoassays for the detection of measles and mumps IgM antibodies in serum. J. Virol. Methods 2014, 196:15-17.
14. Hindiyeh M.Y., Aboudy Y., Wohoush M., Shulman L.M., Ram D., Levin T., Frank T., Riccardo F., Khalili M., Sawalha E.S., Obeidi M., Sabatinelli G., Grossman Z., Mendelson E. Characterization of large mumps outbreak among vaccinated Palestinian refugees. J. Clin. Microbiol. 2009, 47:560-565.
15. Jin L., Vyse A., Brown D.W. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull. World Health Organ. 2002, 80:76-77.
16. Jin L., Rima B., Brown D., Orvell C., Tecle T., Afzal M., Uchida K., Nakayama T., Song J.W., Kang C., Rota P.A., Xu W., Featherstone D. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch. Virol. 2005, 150:1903-1909.
17. Jin L., Örvell C., Myers R., Rota P.A., Nakayama T., Forcic D., Hiebert J., Brown K.E. Genomic diversity of mumps virus and global distribution of the 12 genotypes. Rev. Med. Virol. 2014, 25:85-101. 10.1002/rmv.1819.
18. Koch J., Takla A. Effects of the MMR vaccination on the epidemiology of mumps in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013, 56:1305-1312.
19. Kulkarni-Kale U., Ojha J., Manjari G.S., Deobagkar D.D., Mallya A.D., Dhere R.M., Kapre S.V. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 2007, 359:436-446.
20. Latner D.R., McGrew M., Williams N., Lowe L., Werman R., Warnock E., Gallagher K., Doyle P., Smole S., Lett S., Cocoros N., DeMaria A., Konomi R., Brown C.J., Rota P.A., Bellini W.J., Hickman C.J. Enzyme-linked immunospot assay detection of mumps-specific antibody-secreting B cells as an alternative method of laboratory diagnosis. Clin. Vaccine Immunol.: CVI 2011, 18:35-42.
21. Livingston K.A., Rosen J.B., Zucker J.R., Zimmerman C.M. Mumps vaccine effectiveness and risk factors for disease in households during an outbreak in New York City. Vaccine 2014, 32:369-374.
22. Lopez Hernandez B., Martin Velez R.M., Roman Garcia C., Penalver Sanchez I., Lopez Rosique J.A. An epidemic outbreak of mumps. A study of vaccinal efficacy. Aten. Primaria 2000, 25:148-152. (Sociedad Espanola de Medicina de Familia y Comunitaria).
23. Malaiyan J., Menon T. Low vaccine efficacy of mumps component among MMR vaccine recipients in Chennai, India. Indian J. Med. Res. 2014, 139:773-775.
24. Muhlemann K. The molecular epidemiology of mumps virus. Infect. Genet. Evol. 2004, 4:215-219. (Journal of molecular epidemiology and evolutionary genetics in infectious diseases).
25. Nojd J., Tecle T., Samuelsson A., Orvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001, 19:1727-1731.
26. Orvell C., Tecle T., Johansson B., Saito H., Samuelson A. Antigenic relationships between six genotypes of the small hydrophobic protein gene of mumps virus. J. Gen. Virol. 2002, 83:2489-2496.
27. Otto W., Mankertz A., Santibanez S., Saygili H., Wenzel J., Jilg W., Wieland W., Borgmann S. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill. 2010, 15(50). pii: 19748. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19748.
28. Park D.W., Nam M.H., Kim J.Y., Kim H.J., Sohn J.W., Cho Y., Song K.J., Kim M.J. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements. Vaccine 2007, 25:4665-4670.
29. RKI Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2012. Epidemiol. Bull. 2014, 16:137-141.
30. RKI Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: August 2014. Epidemiol. Bull. 2014, 34:305-340.
31. Rota J.S., Rosen J.B., Doll M.K., McNall R.J., McGrew M., Williams N., Lopareva E.N., Barskey A.E., Punsalang A., Rota P.A., Oleszko W.R., Hickman C.J., Zimmerman C.M., Bellini W.J. Comparison of the sensitivity of laboratory diagnostic methods from a well-characterized outbreak of mumps in New York city in 2009. Clin. Vaccine Immunol. 2013, 20:391-396. (CVI).
32. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 1987, 4:406-425.
33. Santos C.L., Ishida M.A., Foster P.G., Sallum M.A., Benega M.A., Borges D.B., Correa K.O., Constantino C.R., Afzal M.A., Paiva T.M. Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of Sao Paulo, Brazil. J. Med. Virol. 2008, 80:323-329.
34. Takla A., Wichmann O., Klinc C., Hautmann W., Rieck T., Koch J. Mumps epidemiology in Germany 2007-11. Euro Surveill. 2013, 18:20557. (Bulletin Europeen sur les maladies transmissibles=European communicable disease bulletin).
35. Takla A., Bohmer M.M., Klinc C., Kurz N., Schaffer A., Stich H., Stocker P., Wichmann O., Koch J. Outbreak-related mumps vaccine effectiveness among a cohort of children and of young adults in Germany 2011. Hum. Vaccines Immunother. 2014, 10:140-145.
36. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739.
37. Tipples G., Hiebert J. Detection of measles, mumps, and rubella viruses. Methods Mol. Biol. 2011, 665:183-193.
38. Vandermeulen C., Roelants M., Vermoere M., Roseeuw K., Goubau P., Hoppenbrouwers K. Outbreak of mumps in a vaccinated child population: a question of vaccine failure?. Vaccine 2004, 22:2713-2716.
39. WHO Immunological Basis for Immunization: Mumps 2010, WHO.